BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang W, Nardi MA, Borkowsky W, Li Z, Karpatkin S. Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia. Blood. 2009;113:4086-4093. [PMID: 19023115 DOI: 10.1182/blood-2008-09-181073] [Cited by in Crossref: 94] [Cited by in F6Publishing: 104] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Satoh T, Uojima H, Wada N, Takiguchi H, Kaneko M, Nakamura M, Gonda N, Homma M, Hidaka H, Kusano C, Horie R. Introduction of direct-acting antiviral agents alters frequencies of anti-GPIIb/IIIa antibody-producing B cells in chronic hepatitis C patients with thrombocytopenia. Platelets 2023;34:2161498. [PMID: 36597279 DOI: 10.1080/09537104.2022.2161498] [Reference Citation Analysis]
2 Zhang Y, Liu F, Liang X, Zhu J, Han L, Shi X, Cao J, Li Z, Chen W, Xu K, Cheng H. Expression and prognostic value of C-reactive protein in adult immune thrombocytopenia (ITP) patients. Clin Exp Med 2023. [PMID: 36976377 DOI: 10.1007/s10238-023-01043-y] [Reference Citation Analysis]
3 Ramey C, LePera A. A Possible Case of Nitrofurantoin-Associated Immune Thrombocytopenia in a Healthy 45-Year-Old Caucasian Female. Cureus 2023;15:e34654. [PMID: 36895539 DOI: 10.7759/cureus.34654] [Reference Citation Analysis]
4 El Filaly H, Mabrouk M, Atifi F, Guessous F, Akarid K, Merhi Y, Zaid Y. Dissecting Platelet's Role in Viral Infection: A Double-Edged Effector of the Immune System. Int J Mol Sci 2023;24. [PMID: 36768333 DOI: 10.3390/ijms24032009] [Reference Citation Analysis]
5 Ding JN, Feng TT, Sun W, Cai XY, Zhang Y, Zhao WF. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study. World J Gastrointest Surg 2022; 14(11): 1260-1271 [DOI: 10.4240/wjgs.v14.i11.1260] [Reference Citation Analysis]
6 Putry BO, Khairunnisa N, Balga HM, Tjang YS, Thadeus MS, Santosa F, Pasiak TF. Can SARS-CoV-2 trigger new onset of autoimmune disease in adults? A case-based review. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e11328] [Reference Citation Analysis]
7 Yaman F, Andic N, Oguz Davutoglu N, Üsküdar Teke H, Gunduz E. Retrospective Analysis of Patients Diagnosed with Immune Thrombocytopenia After Covid-19 Infection and Review of the Literature. OSMANGAZİ JOURNAL OF MEDICINE 2022. [DOI: 10.20515/otd.1128627] [Reference Citation Analysis]
8 de Castro GLC, da Silva Graça Amoras E, Araújo MS, da Silva Conde SRS, Bichara CDA, Queiroz MAF, Vallinoto ACR. High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection. Eur J Med Res 2022;27. [DOI: 10.1186/s40001-022-00809-6] [Reference Citation Analysis]
9 Satoh T, Takiguchi H, Uojima H, Kubo M, Tanaka C, Yokoyama F, Wada N, Miyazaki K, Hidaka H, Kusano C, Kuwana M, Horie R. B cell-activating factor is involved in thrombocytopenia in patients with liver cirrhosis. Ann Hematol 2022. [PMID: 36098792 DOI: 10.1007/s00277-022-04973-x] [Reference Citation Analysis]
10 Zhan Y, Cao J, Ji L, Zhang M, Shen Q, Xu P, Zhuang X, Qin S, Hua F, Sun L, Li F, Chen H, Cheng Y. Impaired mitochondria of Tregs decreases OXPHOS-derived ATP in primary immune thrombocytopenia with positive plasma pathogens detected by metagenomic sequencing. Exp Hematol Oncol 2022;11:48. [PMID: 36050760 DOI: 10.1186/s40164-022-00304-y] [Reference Citation Analysis]
11 Ogweno G. Challenges in Platelet Functions in HIV/AIDS Management. Infectious Diseases 2022. [DOI: 10.5772/intechopen.105731] [Reference Citation Analysis]
12 Said KB, Al-otaibi A, Aljaloud L, Al-anazi B, Alsolami A, Alreshidi FS; on behalf of the Ha’il COM Research Unit Group. The Frequency and Patterns of Post-COVID-19 Vaccination Syndrome Reveal Initially Mild and Potentially Immunocytopenic Signs in Primarily Young Saudi Women. Vaccines 2022;10:1015. [DOI: 10.3390/vaccines10071015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Tsai T, Jhou H, Fan FS. Conspicuous Response to Direct-Acting Antivirals in Chronic Hepatitis C-related Immune Thrombocytopenia: A Case Report. Cureus 2022. [DOI: 10.7759/cureus.24193] [Reference Citation Analysis]
14 An O, Martyanov A, Panteleev M. Immune thrombocytopenia: what can the systems biology and systems physiology offer? SBPR 2021;1:1-9. [DOI: 10.52455/sbpr.01.202104011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Laali A, Kermanshah Z, Keyvani H, Kaveh V, Karampoor S. Idiopathic thrombocytopenic purpura as a hematologic manifestation of COVID-19 infection: A case report. Respir Med Case Rep 2021;34:101534. [PMID: 34697584 DOI: 10.1016/j.rmcr.2021.101534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Patwardhan P, Landsteiner A, Lal LS, Geevarghese L, Le L, Nandal S, Cuker A. Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis. Ann Hematol 2021. [PMID: 34505942 DOI: 10.1007/s00277-021-04637-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Huang CE, Chang JJ, Wu YY, Huang SH, Chen WM, Hsu CC, Lu CH, Hung CH, Shi CS, Lee KD, Chen CC, Chen MC. Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection. Biomed J 2021:S2319-4170(21)00113-X. [PMID: 34508913 DOI: 10.1016/j.bj.2021.09.001] [Reference Citation Analysis]
18 Napeñas JJ, Patton LL. Bleeding and Clotting Disorders. Burket's Oral Medicine 2021. [DOI: 10.1002/9781119597797.ch18] [Reference Citation Analysis]
19 He Y, Ji D, Lu W, Chen G. The Mechanistic Effects and Clinical Applications of Various Derived Mesenchymal Stem Cells in Immune Thrombocytopenia. Acta Haematol 2022;145:9-17. [PMID: 34515042 DOI: 10.1159/000517989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Alonso-Beato R, Morales-Ortega A, Fernández FJH, Morón AIP, Ríos-Fernández R, Rubio JLC, Centeno NO. Immune thrombocytopenia and COVID-19: Case report and review of literature. Lupus 2021;30:1515-21. [PMID: 34053365 DOI: 10.1177/09612033211021161] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
21 Watts A, Raj K, Gogia P, Toquica Gahona CC, Porcelli M. Secondary Immune Thrombocytopenic Purpura Triggered by COVID-19. Cureus 2021;13:e14505. [PMID: 34007758 DOI: 10.7759/cureus.14505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Hicks SM, Lee CSM, Ali SA, Choi PY, Gardiner EE. The molecular basis of immune-based platelet disorders. Clin Sci (Lond) 2020;134:2807-22. [PMID: 33140828 DOI: 10.1042/CS20191101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Rahman A, Niloofa R, Jayarajah U, De Mel S, Abeysuriya V, Seneviratne SL. Hematological Abnormalities in COVID-19: A Narrative Review. Am J Trop Med Hyg 2021:tpmd201536. [PMID: 33606667 DOI: 10.4269/ajtmh.20-1536] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
24 Tajima S, Matsumoto F, Anzai T, Hara S, Suzuki Y, Ikeda K. A Case of Epistaxis as the First Sign of Acute Idiopathic Thrombocytopenic Purpura. Case Rep Otolaryngol 2021;2021:6612939. [PMID: 33628555 DOI: 10.1155/2021/6612939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Graf C, Elmassry M, Chu VM, Pawar D, Tijani L. Plexus Slim®-Induced Immune Thrombocytopenic Purpura. Cureus 2020. [DOI: 10.7759/cureus.11413] [Reference Citation Analysis]
26 Kocak MZ, Aktas G, Bilgin S, Duman TT, Kurtkulagi O, Atak B, Demirkol ME, Yilmaz EB. An unusual immune thrombocytopenia case associated with dietary supplements containing 3G (Green tea, Ginseng and Guarana). Russ Open Med J 2020;9. [DOI: 10.15275/rusomj.2020.0307] [Reference Citation Analysis]
27 Huang C, Chen W, Wu Y, Shen C, Hsu C, Li C, Chen M, Chang J, Chen Y, Lu C, Shi C, Chen C. Comparison of antiplatelet antibody profiles between hepatitis C virus-associated immune thrombocytopenia and primary immune thrombocytopenia. Platelets. [DOI: 10.1080/09537104.2020.1820975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Wang Y, Liu F, Zhang G, Su Y, Sun X, Chen Q, Wang C, Fu H, He Y, Zhu X, Liu X, Lv M, Zhao X, Zhao X, Li Y, Wang Q, Huang X, Zhang X. Gut microbiome alterations and its link to corticosteroid resistance in immune thrombocytopenia. Sci China Life Sci 2021;64:766-83. [PMID: 32857289 DOI: 10.1007/s11427-020-1788-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Li C, Li J, Ni H. Crosstalk Between Platelets and Microbial Pathogens. Front Immunol 2020;11:1962. [PMID: 32849656 DOI: 10.3389/fimmu.2020.01962] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
30 Thadchanamoorthy V, Dayasiri K. Dengue hemorrhagic fever as a rare cause of chronic immune thrombocytopenic purpura-a pediatric case report. Trop Med Health 2020;48:59. [PMID: 32699523 DOI: 10.1186/s41182-020-00248-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Bennett J, Brown C, Rouse M, Hoffmann M, Ye Z. Immune Thrombocytopenia Purpura Secondary to COVID-19. Cureus 2020;12:e9083. [PMID: 32676257 DOI: 10.7759/cureus.9083] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
32 Zhang X, Gu S, You L, Xu Y, Zhou, Chen Y, Yan R, Jiang H, Li Y, Lv L, Qian W. Gut Microbiome and Metabolome Were Altered and Strongly Associated With Platelet Count in Adult Patients With Primary Immune Thrombocytopenia. Front Microbiol 2020;11:1550. [PMID: 32733424 DOI: 10.3389/fmicb.2020.01550] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Humbert S, Razanamahery J, Payet-Revest C, Bouiller K, Chirouze C. COVID-19 as a cause of immune thrombocytopenia. Med Mal Infect 2020;50:459-60. [PMID: 32445664 DOI: 10.1016/j.medmal.2020.05.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
34 Onisâi M, Vlădăreanu AM, Spînu A, Găman M, Bumbea H. Idiopathic thrombocytopenic purpura (ITP) - new era for an old disease. Rom J Intern Med 2019;57:273-83. [PMID: 31199777 DOI: 10.2478/rjim-2019-0014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
35 Page MJ, Pretorius E. A Champion of Host Defense: A Generic Large-Scale Cause for Platelet Dysfunction and Depletion in Infection. Semin Thromb Hemost 2020;46:302-19. [PMID: 32279287 DOI: 10.1055/s-0040-1708827] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
36 Johira Y, Hatooka H, Mori N, Fukuhara T, Takaki S, Shimomura Y, Imamura M, Hayes CN, Tsuji K, Chayama K. Regression of Idiopathic Thrombocytopenic Purpura in a Patient With Eradication of Hepatitis C Virus by Direct-Acting Antivirals. Hepatology 2020;71:389-91. [PMID: 31432523 DOI: 10.1002/hep.30900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
37 Hirokawa M, Fujishima N, Togashi M, Saga A, Omokawa A, Saga T, Moritoki Y, Ueki S, Takahashi N, Kitaura K, Suzuki R. High-throughput sequencing of IgG B-cell receptors reveals frequent usage of the rearranged IGHV4-28/IGHJ4 gene in primary immune thrombocytopenia. Sci Rep 2019;9:8645. [PMID: 31201346 DOI: 10.1038/s41598-019-45264-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
38 Nurden AT. Acquired Glanzmann thrombasthenia: From antibodies to anti-platelet drugs. Blood Rev 2019;36:10-22. [PMID: 31010659 DOI: 10.1016/j.blre.2019.03.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
39 Chen H, Lin C, Fan Z, Yu W, Cao M, Ke C, Jiao X. Serum cytokines and clinical features in patients with fever and thrombocytopenia syndrome. Clin Chim Acta 2019;494:22-30. [PMID: 30831067 DOI: 10.1016/j.cca.2019.02.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
40 Chaturvedi S, Mccrae KR. Thrombocytopenia in Pregnancy. Platelets 2019. [DOI: 10.1016/b978-0-12-813456-6.00043-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Romano C, Cuomo G, Ferrara R, Del Mastro A, Esposito S, Sellitto A, Adinolfi LE. Uncommon immune-mediated extrahepatic manifestations of HCV infection. Expert Rev Clin Immunol. 2018;14:1089-1099. [PMID: 30338718 DOI: 10.1080/1744666x.2018.1538790] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
42 Swinkels M, Rijkers M, Voorberg J, Vidarsson G, Leebeek FWG, Jansen AJG. Emerging Concepts in Immune Thrombocytopenia. Front Immunol 2018;9:880. [PMID: 29760702 DOI: 10.3389/fimmu.2018.00880] [Cited by in Crossref: 103] [Cited by in F6Publishing: 104] [Article Influence: 20.6] [Reference Citation Analysis]
43 Dang S, Bu D, Lu T, Wang Z, Liu J, Zhang W. Adamts18 deficiency increases arterial thrombus formation associated with vascular defects in mice. Biochemical and Biophysical Research Communications 2018;496:1362-8. [DOI: 10.1016/j.bbrc.2018.02.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
44 Kuwana M. Current understanding of the mechanisms for autoantibody production. Nihon Kessen Shiketsu Gakkaishi 2018;29:243-250. [DOI: 10.2491/jjsth.29.243] [Reference Citation Analysis]
45 Olmsted Kim T. Pathophysiology of Immune Thrombocytopenia. Immune Hematology 2018. [DOI: 10.1007/978-3-319-73269-5_2] [Reference Citation Analysis]
46 Kapur R, Semple JW. Immune Functions of Platelets. Antibody Therapy 2018. [DOI: 10.1007/978-3-319-68038-5_17] [Reference Citation Analysis]
47 Segna D, Dufour JF. Other Extrahepatic Manifestations of Hepatitis C Virus Infection (Pulmonary, Idiopathic Thrombocytopenic Purpura, Nondiabetes Endocrine Disorders). Clin Liver Dis 2017;21:607-29. [PMID: 28689597 DOI: 10.1016/j.cld.2017.03.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
48 Lomakin Y, Arapidi GP, Chernov A, Ziganshin R, Tcyganov E, Lyadova I, Butenko IO, Osetrova M, Ponomarenko N, Telegin G, Govorun VM, Gabibov A, Belogurov A Jr. Exposure to the Epstein-Barr Viral Antigen Latent Membrane Protein 1 Induces Myelin-Reactive Antibodies In Vivo. Front Immunol 2017;8:777. [PMID: 28729867 DOI: 10.3389/fimmu.2017.00777] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
49 Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmunity Reviews 2017;16:620-32. [DOI: 10.1016/j.autrev.2017.04.012] [Cited by in Crossref: 150] [Cited by in F6Publishing: 126] [Article Influence: 25.0] [Reference Citation Analysis]
50 Pryzdial ELG, Lin BH, Sutherland MR. Virus–Platelet Associations. Platelets in Thrombotic and Non-Thrombotic Disorders 2017. [DOI: 10.1007/978-3-319-47462-5_72] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
51 Zufferey A, Kapur R, Semple JW. Pathogenesis and Therapeutic Mechanisms in  Immune Thrombocytopenia (ITP). J Clin Med 2017;6:E16. [PMID: 28208757 DOI: 10.3390/jcm6020016] [Cited by in Crossref: 207] [Cited by in F6Publishing: 217] [Article Influence: 34.5] [Reference Citation Analysis]
52 Satoh T, Kuwana M. Differential Diagnosis: Secondary ITP. Autoimmune Thrombocytopenia 2017. [DOI: 10.1007/978-981-10-4142-6_9] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
53 Franchini M, Veneri D, Lippi G. Thrombocytopenia and infections. Expert Rev Hematol 2017;10:99-106. [PMID: 27936979 DOI: 10.1080/17474086.2017.1271319] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
54 Moukhadder HM, Chaya BF, Bazarbachi AA, Taher AT. Immune thrombocytopenia: a comprehensive review from pathophysiology to promising treatment modalities. Expert Opinion on Orphan Drugs 2016;4:1217-27. [DOI: 10.1080/21678707.2016.1247691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
55 Kapur R, Semple JW. The nonhemostatic immune functions of platelets. Semin Hematol 2016;53 Suppl 1:S2-6. [PMID: 27312157 DOI: 10.1053/j.seminhematol.2016.04.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
56 Chae WJ, Ehrlich AK, Chan PY, Teixeira AM, Henegariu O, Hao L, Shin JH, Park JH, Tang WH, Kim ST, Maher SE, Goldsmith-Pestana K, Shan P, Hwa J, Lee PJ, Krause DS, Rothlin CV, McMahon-Pratt D, Bothwell AL. The Wnt Antagonist Dickkopf-1 Promotes Pathological Type 2 Cell-Mediated Inflammation. Immunity 2016;44:246-58. [PMID: 26872695 DOI: 10.1016/j.immuni.2016.01.008] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 12.4] [Reference Citation Analysis]
57 Kapur R, Semple JW. Platelet Functions Beyond Hemostasis. Molecular and Cellular Biology of Platelet Formation 2016. [DOI: 10.1007/978-3-319-39562-3_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
58 Kapur R, Zufferey A, Boilard E, Semple JW. Nouvelle cuisine: platelets served with inflammation. J Immunol 2015;194:5579-87. [PMID: 26048965 DOI: 10.4049/jimmunol.1500259] [Cited by in Crossref: 135] [Cited by in F6Publishing: 209] [Article Influence: 16.9] [Reference Citation Analysis]
59 Zhou Y, Jing F, Shen N, Liu M, Wang J, Hong T, Dang S, Zhang W. Integrin GPIIIa49-57 is the pivotal switch controlling platelet fragmentation. Platelets 2015;26:693-8. [DOI: 10.3109/09537104.2015.1010440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 Kapur R, Heitink-pollé KMJ, Porcelijn L, Bentlage AEH, Bruin MCA, Visser R, Roos D, Schasfoort RBM, de Haas M, van der Schoot CE, Vidarsson G. C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia. Blood 2015;125:1793-802. [DOI: 10.1182/blood-2014-05-579110] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 6.5] [Reference Citation Analysis]
61 Franzetti M, Adorni F, Oreni L, Van Den Bogaart L, Resnati C, Milazzo L, Antinori S, Galli M, Ridolfo AL. Changes in the incidence of severe thrombocytopenia and its predisposing conditions in HIV-infected patients since the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2014;67:493-8. [PMID: 25230291 DOI: 10.1097/QAI.0000000000000347] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
62 Assinger A. Platelets and infection - an emerging role of platelets in viral infection. Front Immunol 2014;5:649. [PMID: 25566260 DOI: 10.3389/fimmu.2014.00649] [Cited by in Crossref: 212] [Cited by in F6Publishing: 225] [Article Influence: 23.6] [Reference Citation Analysis]
63 Rinaldi M, Perricone C, Ortega-Hernandez OD, Perricone R, Shoenfeld Y. Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines. Lupus 2014;23:554-67. [PMID: 24763539 DOI: 10.1177/0961203313499959] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 4.9] [Reference Citation Analysis]
64 Tampaki M, Koskinas J. Extrahepatic immune related manifestations in chronic hepatitis C virus infection. World J Gastroenterol 2014; 20(35): 12372-12380 [PMID: 25253938 DOI: 10.3748/wjg.v20.i35.12372] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
65 Cines DB, Cuker A, Semple JW. Pathogenesis of immune thrombocytopenia. La Presse Médicale 2014;43:e49-59. [DOI: 10.1016/j.lpm.2014.01.010] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 7.8] [Reference Citation Analysis]
66 Abadi U, Yarchovsky-dolberg O, Ellis MH. Immune Thrombocytopenia: Recent Progress in Pathophysiology and Treatment. Clin Appl Thromb Hemost 2015;21:397-404. [DOI: 10.1177/1076029614526639] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
67 Pant M, Acharya P, Bhatt V, Silberstein P. Immune Thrombocytopenia☆. Reference Module in Biomedical Sciences 2014. [DOI: 10.1016/b978-0-12-801238-3.05080-7] [Reference Citation Analysis]
68 Gruson B, Bussel JB. Immune Thrombocytopenia. The Autoimmune Diseases 2014. [DOI: 10.1016/b978-0-12-384929-8.00047-2] [Reference Citation Analysis]
69 Kistangari G, McCrae KR. Immune thrombocytopenia. Hematol Oncol Clin North Am 2013;27:495-520. [PMID: 23714309 DOI: 10.1016/j.hoc.2013.03.001] [Cited by in Crossref: 109] [Cited by in F6Publishing: 82] [Article Influence: 10.9] [Reference Citation Analysis]
70 Zhang W. Platelet Fragmentation: A Novel Opinion for Thrombosis Therapy: Platelet Ligand Dissolves Thrombi. Drug Dev Res 2013;74:553-7. [DOI: 10.1002/ddr.21114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
71 Kashiwagi H, Tomiyama Y. Pathophysiology and management of primary immune thrombocytopenia. Int J Hematol 2013;98:24-33. [DOI: 10.1007/s12185-013-1370-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
72 Danish FI, Yasmin S. The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia. Hepat Med 2013;5:17-30. [PMID: 24696622 DOI: 10.2147/HMER.S27100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
73 Yehudai D, Toubi E, Shoenfeld Y, Vadasz Z. Autoimmunity and Novel Therapies in Immune-Mediated Thrombocytopenia. Seminars in Hematology 2013;50:S100-8. [DOI: 10.1053/j.seminhematol.2013.03.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
74 Mccrae KR. Thrombocytopenia in Pregnancy. Platelets 2013. [DOI: 10.1016/b978-0-12-387837-3.00044-4] [Reference Citation Analysis]
75 Fan J, Jing F, Dang S, Zhang W. Protective effects of bifunctional platelet GPIIIa49-66 ligand on myocardial ischemia-reperfusion injury in rats. Health 2013;05:15-20. [DOI: 10.4236/health.2013.57a3003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
76 Chan T, Wood K, Hermes J, Butt D, Jolly C, Basten A, Brink R. Elimination of Germinal-Center-Derived Self-Reactive B Cells Is Governed by the Location and Concentration of Self-Antigen. Immunity 2012;37:893-904. [DOI: 10.1016/j.immuni.2012.07.017] [Cited by in Crossref: 100] [Cited by in F6Publishing: 101] [Article Influence: 9.1] [Reference Citation Analysis]
77 Li C, Li J, Li Y, Lang S, Yougbare I, Zhu G, Chen P, Ni H. Crosstalk between Platelets and the Immune System: Old Systems with New Discoveries. Adv Hematol 2012;2012:384685. [PMID: 23008717 DOI: 10.1155/2012/384685] [Cited by in Crossref: 81] [Cited by in F6Publishing: 170] [Article Influence: 7.4] [Reference Citation Analysis]
78 Zhang W, Dang S, Hong T, Tang J, Fan J, Bu D, Sun Y, Wang Z, Wisniewski T. A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment. Blood. 2012;120:2889-2898. [PMID: 22879538 DOI: 10.1182/blood-2012-04-425207] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
79 Zucker ML, Hagedorn CH, Murphy CA, Stanley S, Reid KJ, Skikne BS. Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction. Int J Lab Hematol 2012;34:525-32. [PMID: 22708981 DOI: 10.1111/j.1751-553X.2012.01429.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
80 Chan TD, Brink R. Affinity-based selection and the germinal center response: Affinity selection in the GC response. Immunological Reviews 2012;247:11-23. [DOI: 10.1111/j.1600-065x.2012.01118.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 6.2] [Reference Citation Analysis]
81 Dang S, Bu D, Hong T, Zhang W. A polyclonal antibody against active C-terminal ADAMTS-18 fragment. Hybridoma (Larchmt) 2011;30:567-9. [PMID: 22149285 DOI: 10.1089/hyb.2011.0055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
82 Dang S, Hong T, Ding BS, Zhang W. A humanized single-chain variable fragment antibody against beta3 integrin in Escherichia coli. Hybridoma (Larchmt) 2011;30:543-8. [PMID: 22149280 DOI: 10.1089/hyb.2011.0056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
83 Warter L, Appanna R, Fink K. Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology. Immunol Res 2012;53:148-61. [DOI: 10.1007/s12026-012-8268-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
84 Dang S, Hong T, Bu D, Tang J, Fan J, Zhang W. Optimized refolding and characterization of active C-terminal ADAMTS-18 fragment from inclusion bodies of Escherichia coli. Protein Expression and Purification 2012;82:32-6. [DOI: 10.1016/j.pep.2011.11.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
85 Ho WL, Lee CC, Chen CJ, Lu MY, Hu FC, Jou ST, Lin DT, Lin KH. Clinical features, prognostic factors, and their relationship with antiplatelet antibodies in children with immune thrombocytopenia. J Pediatr Hematol Oncol 2012;34:6-12. [PMID: 22215094 DOI: 10.1097/MPH.0b013e3182282548] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
86 Toltl LJ, Nazi I, Jafari R, Arnold DM. Piecing together the humoral and cellular mechanisms of immune thrombocytopenia. Semin Thromb Hemost 2011;37:631-9. [PMID: 22102266 DOI: 10.1055/s-0031-1291373] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
87 Dang S, Hong T, Wisniewski T, Zhang W. Dissolution of pre-existing platelet thrombus by synergistic administration of low concentrations of bifunctional antibodies against β3 integrin. PLoS One 2011;6:e27012. [PMID: 22046432 DOI: 10.1371/journal.pone.0027012] [Reference Citation Analysis]
88 McCrae K. Immune thrombocytopenia: no longer ‘idiopathic’. Cleve Clin J Med. 2011;78:358-373. [PMID: 21632906 DOI: 10.3949/ccjm.78gr.10005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
89 Cuker A, Cines DB. Immune thrombocytopenia. Hematology Am Soc Hematol Educ Program 2010;2010:377-84. [PMID: 21239822 DOI: 10.1182/asheducation-2010.1.377] [Cited by in Crossref: 43] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
90 Semple JW, Provan D, Garvey MB, Freedman J. Recent progress in understanding the pathogenesis of immune thrombocytopenia. Curr Opin Hematol. 2010;17:590-595. [PMID: 20739879 DOI: 10.1097/moh.0b013e32833eaef3] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 5.0] [Reference Citation Analysis]
91 Miller JL, Rao AK. Blood Platelets and von Willebrand Disease. Henry's Clinical Diagnosis and Management by Laboratory Methods 2011. [DOI: 10.1016/b978-1-4377-0974-2.00040-3] [Reference Citation Analysis]
92 Cuker A, Cines DB. Immune Thrombocytopenia. Hematology 2010;2010:377-84. [DOI: 10.1182/asheducation.v2010.1.377.3643150] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
93 Stasi R. Pathophysiology and therapeutic options in primary immune thrombocytopenia. Blood Transfus 2011;9:262-73. [PMID: 21251458 DOI: 10.2450/2010.0080-10] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
94 Audia S, Lorcerie B, Godeau B, Bonnotte B. [Pathophysiology of immune thrombocytopenia]. Rev Med Interne 2011;32:350-7. [PMID: 20557985 DOI: 10.1016/j.revmed.2009.05.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
95 Zehnder JL, Semple JW, Imbach P, Neufeld EJ, Buchanan GR, Cines DB; ICIS Study Group on Future Research in ITP. Future research in ITP: an ICIS consensus. Ann Hematol 2010;89:19-23. [DOI: 10.1007/s00277-010-0917-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
96 Pang SJ, Lazarus AH. Mechanisms of platelet recovery in ITP associated with therapy. Ann Hematol 2010;89 Suppl 1:31-5. [PMID: 20179926 DOI: 10.1007/s00277-010-0916-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
97 Turbyville JC, Rao VK. The autoimmune lymphoproliferative syndrome: A rare disorder providing clues about normal tolerance. Autoimmun Rev 2010;9:488-93. [PMID: 20170754 DOI: 10.1016/j.autrev.2010.02.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
98 Semple JW. Infections, antigen-presenting cells, T cells, and immune tolerance: their role in the pathogenesis of immune thrombocytopenia. Hematol Oncol Clin North Am 2009;23:1177-92. [PMID: 19932427 DOI: 10.1016/j.hoc.2009.08.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
99 Stasi R, Willis F, Shannon MS, Gordon-Smith EC. Infectious causes of chronic immune thrombocytopenia. Hematol Oncol Clin North Am. 2009;23:1275-1297. [PMID: 19932434 DOI: 10.1016/j.hoc.2009.08.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
100 Klco JM, Geng B, Brunt EM, Hassan A, Nguyen TD, Kreisel FH, Lisker-Melman M, Frater JL. Bone marrow biopsy in patients with hepatitis C virus infection: spectrum of findings and diagnostic utility. Am J Hematol 2010;85:106-10. [PMID: 20095034 DOI: 10.1002/ajh.21600] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
101 Aref S, Sleem T, El Menshawy N, Ebrahiem L, Abdella D, Fouda M, Samara NA, Menessy A, Abdel-Ghaffar H, Bassam A. Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infection. Hematology. 2009;14:277-281. [PMID: 19843383 DOI: 10.1179/102453309x439818] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
102 Kuwana M. Molecular mechanisms for developing immune thrombocytopenic purpura. Nihon Kessen Shiketsu Gakkaishi 2010;21:255-261. [DOI: 10.2491/jjsth.21.255] [Reference Citation Analysis]
103 Stasi R, Chia LW, Kalkur P, Lowe R, Shannon MS. Pathobiology and treatment of hepatitis virus-related thrombocytopenia. Mediterr J Hematol Infect Dis 2009;1:e2009023. [PMID: 21415958 DOI: 10.4084/MJHID.2009.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
104 Bonnotte B. Physiopathologie du Purpura Thrombopénique Idiopathique. La Revue de Médecine Interne 2009;30:H2-5. [DOI: 10.1016/s0248-8663(09)72465-8] [Reference Citation Analysis]
105 Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009;46:S2-S14. [PMID: 19245930 DOI: 10.1053/j.seminhematol.2008.12.005] [Cited by in Crossref: 132] [Cited by in F6Publishing: 150] [Article Influence: 9.4] [Reference Citation Analysis]
106 Aster RH. Molecular mimicry and immune thrombocytopenia. Blood 2009;113:3887-8. [PMID: 19389889 DOI: 10.1182/blood-2008-12-193664] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
107 Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113:6511-6521. [PMID: 19395674 DOI: 10.1182/blood-2009-01-129155] [Cited by in Crossref: 498] [Cited by in F6Publishing: 530] [Article Influence: 35.6] [Reference Citation Analysis]
108 Li Z, Nardi MA, Li YS, Zhang W, Pan R, Dang S, Yee H, Quartermain D, Jonas S, Karpatkin S. C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral stroke. Blood 2009;113:6051-60. [PMID: 19218546 DOI: 10.1182/blood-2008-07-170571] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]